- Filed
- Nov 28, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Nov 25, 2025 | 75.12M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2025 | 23.26M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 14.18M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $6.94K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2025 | −$2.15M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.35M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $17.7M |
| Short Term Debt restated | Q1 2025 · Mar 31, 2025 | $7.53M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $107.47M |
| Current Liabilities restated | Q1 2025 · Mar 31, 2025 | $37.84M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $157.73M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2025 | $55.57M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $157.73M |
| Current Assets restated | Q1 2025 · Mar 31, 2025 | $5.02M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.07M |
| Total Assets restated | Q1 2025 · Mar 31, 2025 | $5.1M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.15M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2025 | −$0.77 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.34 |
| Eps Basic restated | Q1 2025 · Mar 31, 2025 | −$0.77 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.34 |
| Sga Expense restated | Q1 2025 · Mar 31, 2025 | $14.66M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.11M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $1.02M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $875.34K |
| Net Income restated | Q1 2025 · Mar 31, 2025 | −$17.91M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.44M |
| Operating Income restated | Q1 2025 · Mar 31, 2025 | −$15.59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.99M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $101.82K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2025 | $244.23K |
| Revenue restated | Q1 2025 · Mar 31, 2025 | $346.05K |